UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 181

Sortiert nach

The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study

Journal of gastroenterology, 2018-11, Vol.53 (11), p.1216-1224

2018

Volltextzugriff (PDF)

Artificial intelligence/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Hepatology research, 2021-05, Vol.51 (5), p.554-569

2021

Volltextzugriff (PDF)

Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial

The American journal of gastroenterology, 2023-08, Vol.118 (8), p.1365-1372

2023

Volltextzugriff (PDF)

Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease

Journal of gastroenterology, 2020-01, Vol.55 (1), p.100-112

2020

Volltextzugriff (PDF)

A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis

Journal of gastroenterology, 2018, Vol.53 (1), p.129-139

2018

Volltextzugriff (PDF)

Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers

PloS one, 2018-01, Vol.13 (1), p.e0185490-e0185490

2018

Volltextzugriff (PDF)

Novel artificial intelligent/neural network system for staging of nonalcoholic steatohepatitis

Hepatology research, 2021-10, Vol.51 (10), p.1044-1057

2021

Volltextzugriff (PDF)

Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease

BMC gastroenterology, 2012-02, Vol.12 (1), p.16-16, Article 16

2012

Volltextzugriff (PDF)

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese

PloS one, 2012-06, Vol.7 (6), p.e38322-e38322

2012

Volltextzugriff (PDF)

Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients

Journal of gastroenterology, 2019-01, Vol.54 (1), p.64-77

2019

Volltextzugriff (PDF)

Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma

Journal of gastroenterology, 2018-06, Vol.53 (6), p.770-779

2018

Volltextzugriff (PDF)

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease

Journal of gastroenterology, 2011, Vol.46 (1), p.101-107

2011

Volltextzugriff (PDF)

Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis‐related fibrosis: Multicenter study

Hepatology research, 2023-04, Vol.53 (4), p.312-321

2023

Volltextzugriff (PDF)

Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma

Anticancer research, 2019-09, Vol.39 (9), p.5149-5156

2019

Volltextzugriff (PDF)

A novel rapid immunoassay of serum type IV collagen 7S for the diagnosis of fibrosis stage of nonalcoholic fatty liver diseases

Hepatology research, 2021-03, Vol.51 (3), p.263-276

2021

Volltextzugriff (PDF)

Identification of novel noninvasive markers for diagnosing nonalcoholic steatohepatitis and related fibrosis by data mining

Hepatology (Baltimore, Md.), 2016-02, Vol.63 (2), p.462-473

2016

Volltextzugriff (PDF)

Pancreaticopleural Fistula Resulting in Formation of Mediastinal Pseudocysts

Internal Medicine, 2019/04/01, Vol.58(7), pp.1041-1042

2019

Volltextzugriff (PDF)

Serum levels of immunoglobulin M‐free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis‐associated hepatocellular carcinoma

Hepatology research, 2022-12, Vol.52 (12), p.998-1008

2022

Volltextzugriff (PDF)

Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13354

2021

Volltextzugriff (PDF)

Misunderstanding of hepatitis C virus (HCV) infection status by non–specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-09, Vol.28 (9), p.1231-1234

2022

Volltextzugriff (PDF)

Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma

Hepatology research, 2012-08, Vol.42 (8), p.767-773

2012

Volltextzugriff (PDF)

Garcin Syndrome Due to Meningeal Carcinomatosis from Gastric Cancer

Internal Medicine, 2021/03/15, Vol.60(6), pp.855-858

2021

Volltextzugriff (PDF)

Comparison of thrombocytopenia between patients with non‐alcoholic fatty liver disease and those with hepatitis C virus‐related chronic liver disease

Hepatology research, 2022-08, Vol.52 (8), p.677-686

2022

Volltextzugriff (PDF)

Influence of lifestyle-related diseases and age on the development and progression of non-alcoholic fatty liver disease

Hepatology research, 2015-05, Vol.45 (5), p.548-559

2015

Volltextzugriff (PDF)

Accuracy of non‐invasive scoring systems for diagnosing non‐alcoholic steatohepatitis‐related fibrosis: Multicenter validation study

Hepatology research, 2018-12, Vol.48 (13), p.1099-1107

2018

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(170)

Publikationsform

Artikel
(180)
Tagungsberichte
(1)

Sprache

Englisch
(158)
Japanisch
(77)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study

Artificial intelligence/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial

Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease

A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis

Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers

Novel artificial intelligent/neural network system for staging of nonalcoholic steatohepatitis

Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese

Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients

Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease

Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis‐related fibrosis: Multicenter study

Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma

A novel rapid immunoassay of serum type IV collagen 7S for the diagnosis of fibrosis stage of nonalcoholic fatty liver diseases

Identification of novel noninvasive markers for diagnosing nonalcoholic steatohepatitis and related fibrosis by data mining

Pancreaticopleural Fistula Resulting in Formation of Mediastinal Pseudocysts

Serum levels of immunoglobulin M‐free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis‐associated hepatocellular carcinoma

Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells

Misunderstanding of hepatitis C virus (HCV) infection status by non–specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy

Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma

Garcin Syndrome Due to Meningeal Carcinomatosis from Gastric Cancer

Comparison of thrombocytopenia between patients with non‐alcoholic fatty liver disease and those with hepatitis C virus‐related chronic liver disease

Influence of lifestyle-related diseases and age on the development and progression of non-alcoholic fatty liver disease

Accuracy of non‐invasive scoring systems for diagnosing non‐alcoholic steatohepatitis‐related fibrosis: Multicenter validation study

Suchergebnisse filtern